GFFFX
Price
$71.29
Change
-$0.00 (-0.00%)
Updated
Sep 6 closing price
JRANX
Price
$77.34
Change
-$0.00 (-0.00%)
Updated
Sep 6 closing price
Ad is loading...

GFFFX vs JRANX

Header iconGFFFX vs JRANX Comparison
Open Charts GFFFX vs JRANXBanner chart's image
American Funds Growth Fund of Amer F2
Price$71.29
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Janus Henderson Research N
Price$77.34
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
GFFFX vs JRANX Comparison Chart
Loading...
VS
GFFFX vs. JRANX commentary
Sep 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFFFX is a StrongBuy and JRANX is a Buy.

FUNDAMENTALS
Fundamentals
GFFFX has more cash in the bank: 284B vs. JRANX (23.3B). GFFFX pays higher dividends than JRANX: GFFFX (0.67) vs JRANX (0.11). GFFFX was incepted earlier than JRANX: GFFFX (16 years) vs JRANX (12 years). GFFFX is a more actively managed with annual turnover of: 31.00 vs. JRANX (27.00). GFFFX has a lower initial minimum investment than JRANX: GFFFX (250) vs JRANX (1000000). JRANX annual gain was more profitable for investors over the last year : 31.37 vs. GFFFX (21.62). JRANX return over 5 years is better than : 64.34 vs. GFFFX (50.70).
GFFFXJRANXGFFFX / JRANX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years12 years-
Gain YTD19.29424.96677%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets284B23.3B1,219%
Annual Yield % from dividends0.670.11641%
Returns for 1 year21.6231.3769%
Returns for 3 years-2.5911.49-23%
Returns for 5 years50.7064.3479%
Returns for 10 years64.3979.4581%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VECO31.251.19
+3.96%
Veeco Instruments
OSK100.372.71
+2.77%
Oshkosh Corp
PRME4.090.04
+0.99%
Prime Medicine
ACRS1.180.01
+0.85%
Aclaris Therapeutics
UK1.44-0.01
-0.69%
Ucommune International Ltd